COSELA™ (Trilaciclib)
- Medicine Name: Cosela
- Generic Name: Trilacicilib
- Dosage Form & Strength: Injection: 300 mg
- Manufactured By: G1 Therapeutics, Inc.
Medical Uses
Cosela is a kinase inhibitor used to mitigate the incidence of chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive-stage small cell lung cancer.
Recommended Dosage: The recommended dose is 240 mg/m2 per dose. Cosela is for intravenous use only. Administer as a 30-minute intravenous infusion completed within four hours before the initiation of chemotherapy on each day chemotherapy is administered. The interval between doses of Cosela Injection on sequential days should not be greater than 28 hours.
If the dose is missed, discontinue chemotherapy on the day the dose of Cosela was missed. Consider resuming both chemotherapy and Cosela on the next scheduled day for chemotherapy.
Warning & Precautions
- Administration of Trilacicilib can be responsible for causing injection-site reactions including phlebitis and thrombophlebitis. Assess patients for signs/symptoms of injection-site reactions, phlebitis, and thrombophlebitis, including infusion-site pain and erythema during infusion.
- Administration of Trilacicilib 300 mg injection can cause acute drug hypersensitivity reactions, including facial edema and urticaria. Evaluate patients for signs/symptoms of acute drug hypersensitivity reactions including eye, facial, and tongue edema, pruritus, urticaria, and anaphylactic reactions.
- Serious, life-threatening, or fatal interstitial lung disease (ILD) and/or pneumonitis can emerge in patients treated with cyclin-dependent kinases (CDK)4/6 inhibitors, the same drug class as Trilacicilib.
- Monitor patients for pulmonary symptoms indicative of ILD/pneumonitis such as dyspnea, cough, and hypoxia. For recurrent moderate ILD/pneumonitis, permanently interrupt Trilacicilib. For severe or life-threatening (Grade 4) ILD/pneumonitis, permanently interrupt Trilacicilib.
- Based on its mechanism of action, Cosela 300 mg injection can cause fetal harm if administered to a pregnant woman. Females of reproductive age should use an apt contraception during treatment and for at least three weeks after the final dose.
- Because of the potential for severe adverse reactions in breastfed children, lactating women should not breastfeed while taking treatment with trilacicilib injectable and for at least 3 weeks after the final dose.
Documentation & Availability
What documents are required to import COSELA to India?
COSELA (trilacicilib) injection can be imported by patients or government hospitals on the name of the patients only.
The following documentation are needed to import the product:
- A valid prescription from a qualified doctor.
- Patient’s diagnostic reports.
- Patient’s ID proof (issued by the Government of India).
How is the order confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from a doctor.
- Import permit if applicable.
Is COSELA available in India?
COSELA (trilacicilib injection) is a (prescription drug, prescription medication or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
S S Healthcare (S S Healthcare) helps import cancer medicines on the named patient supply (NPS). S S Healthcare is facilitator providing input
- On availability of Cosela injection in India (Delhi, Mumbai, Kolkata, Hyderabad, Ahmedabad, Pune, Chennai and Bangalore etc.)
- Medicine Price.
- Finding Genuine and reliable source from Canada, Europe, USA and Australia
- Ensuring 100% transparency.
COSELA can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and import permit.
S S Healthcare (S S Healthcare) can facilitate the supply of COSELA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable)
Please contact +91-7575883015 | Toll-Free No: +91-7575883015 or write us at sshealthcare1012@gmail.com for Cosela injection price in India.
We take guarantee of quality and delivery anywhere in the world as per the buyer’s requirements.
Sourcing & Delivery
S S Healthcare is able to source the COSELA (Cancer Treatment Medicines) from across the globe, and has the ability to supply. S S Healthcare offers its customers worldwide access to the best available treatment.
S S Healthcare is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
FAQ
What is the Generic Name for the trade name drug Cosela®?
Trilacicilib is Generic Name for the trade name drug Cosela®.
What is the Manufacturer Name of Cosela®?
Cosela® is manufactured by G1 Therapeutics, Inc.
Is Cosela® approved by the FDA?
Yes, Cosela® is approved by the FDA. Date of approval: February 12, 2021.
What is Cosela®?
Cosela® is a cyclin-dependent kinase 4/6 (CDK4/6) inhibitor myelopreservation therapy for use in patients with SCLC who are receiving chemotherapy.
What is the dosage and form of Cosela® supplied?
Cosela® is supplied for injection: 300 mg of trilaciclib as a lyophilized cake in a single-dose vial for intravenous administration.
What are the most common side effects due to Cosela®?
Most common side effects due to Cosela® include: fatigue, hypokalemia, hypocalcemia, hypophosphatemia, aspartate aminotransferase increased, headache, and pneumonia.
How much does Cosela® cost in India?
Cosela cost in India is reasonable. In order to procure this small cell lung cancer medication authentically, you can call or WhatsApp +91-7575883015 or send mail to sshealthcare1012@gmail.com.
What are the storage conditions of Cosela®?
Store the vials of Cosela at 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). The vial stopper is not made with natural rubber latex.
What are the Highlights of prescribing information for Cosela®?
Click Here to download full Cosela prescribing information.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Email Address
Sshealthcare1012@gmail.com
+91 7575883015
Landline
079 48916267
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners, and S S Healthcare does not lay any claim on them. We only provide information.
